Kamada VP acquires options on 15K and 60K shares

The options vest in four equal installments on the four grant-date anniversaries, and the reported USD exercise prices reflect adjustments tied to a special cash dividend.

Rhea-AI Filing Summary

KAMADA LTD reported indirect acquisitions of employee stock options covering 15,000 and 60,000 ordinary shares in transactions reported for VP Plasma Operations Beladev Shavit on August 27, 2026. The options are held by a trustee under the company’s 2011 Share Award Plan. Their exercise prices were adjusted in connection with a special cash dividend declared August 17, 2026, with a record date of August 27, 2026. The options are denominated in NIS, with exercise prices presented in USD as $5.98 and $7.44. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Grant/Award: 75,000 shares

Grant/Award 2 txns

Insider Beladev Shavit

Role VP Plasma Operations

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option(right to buy) F1, F4, F2, F3	15,000	$0.00	$0.00
Grant/Award	Employee Stock Option(right to buy) F1, F5, F2, F3	60,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option(right to buy) — 75,000 contracts (Indirect, Held by trustee)

Footnotes (5)

1. F1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.
2. F2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.
3. F3. Held by trustee under the Company's 2011 Share Award Plan.
4. F4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.
5. F5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Key Figures

Underlying ordinary shares covered: 15,000 shares Underlying ordinary shares covered: 60,000 shares Exercise price: $5.98 per share +3 more

6 metrics

Underlying ordinary shares covered 15,000 shares Employee stock option reported August 27, 2026; held by a trustee

Underlying ordinary shares covered 60,000 shares Employee stock option reported August 27, 2026; held by a trustee

Exercise price $5.98 per share Presented in USD; option covering 15,000 ordinary shares

Exercise price $7.44 per share Presented in USD; option covering 60,000 ordinary shares

Vesting installments 4 equal installments 25% vests on each of the four grant-date anniversaries

Vesting per installment 25% Vests on each of the four grant-date anniversaries

Key Terms

exercise price, vest in four equal installments, special cash dividend distribution, 2011 Share Award Plan

4 terms

exercise price financial

"exercise price has been adjusted"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in four equal installments financial

"Options vest in four equal installments"

special cash dividend distribution financial

"in connection with a special cash dividend distribution"

2011 Share Award Plan financial

"under the Company's 2011 Share Award Plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KMDA options were reported for Beladev Shavit?

The transactions report employee stock options covering 15,000 and 60,000 ordinary shares, both held by a trustee under KAMADA LTD’s 2011 Share Award Plan. They were reported for VP Plasma Operations Beladev Shavit on August 27, 2026.

What are the exercise prices for KMDA’s reported options?

The exercise prices are presented as $5.98 for the option covering 15,000 ordinary shares and $7.44 for the option covering 60,000 ordinary shares. The options are denominated in NIS, with USD presentation based on the Bank of Israel exchange rate published as of September 22, 2026.

How do the KMDA options vest?

Each option vests in four equal installments, with 25% vesting on each of the four anniversaries of the grant date.

Why were the KMDA option exercise prices adjusted?

The exercise prices were adjusted in connection with a special cash dividend distribution declared by KAMADA LTD’s board on August 17, 2026, with a record date of August 27, 2026. The options had previously been reported at $6.15 and $7.61, respectively.

Were the KMDA option transactions under a 10b5-1 plan?

No Rule 10b5-1 plan is reported for these transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/24/2026 - 07:34 AM Accepted by SEC EDGAR 09/24/2026 - 07:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beladev Shavit

(Last) (First) (Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT L3

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Plasma Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option(right to buy)	$5.98(1)(4)	08/27/2026		A		15,000		(2)	(2)	Ordinary Shares	15,000	$0.00	15,000	I	Held by trustee(3)
Employee Stock Option(right to buy)	$7.44(1)(5)	08/27/2026		A		60,000		(2)	(2)	Ordinary Shares	60,000	$0.00	60,000	I	Held by trustee(3)

Explanation of Responses:

1. The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

2. Options vest in four equal installments, with 25% vesting on each of the four anniversaries of the date of grant.

3. Held by trustee under the Company's 2011 Share Award Plan.

4. This option was previously reported as covering 15,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

5. This option was previously reported as covering 60,000 ordinary shares at an exercise price of $7.61. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

	/s/ Shavit Beladev	09/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)